OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Modelling the Functions of Polo-Like Kinases in Mice and Their Applications as Cancer Targets with a Special Focus on Ovarian Cancer
Monika Kressin, Daniela Fietz, Sven Becker, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 1176-1176
Open Access | Times Cited: 15
Monika Kressin, Daniela Fietz, Sven Becker, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 1176-1176
Open Access | Times Cited: 15
Showing 15 citing articles:
The Role of Polo-Like Kinase 1 in Regulating the Forkhead Box Family Transcription Factors
Xavier T.R. Moore, Lilia Gheghiani, Zheng Fu
Cells (2023) Vol. 12, Iss. 9, pp. 1344-1344
Open Access | Times Cited: 11
Xavier T.R. Moore, Lilia Gheghiani, Zheng Fu
Cells (2023) Vol. 12, Iss. 9, pp. 1344-1344
Open Access | Times Cited: 11
MEK1/2 inhibitors suppress pathological α-synuclein and neurotoxicity in cell models and a humanized mouse model of Parkinson’s disease
Huilan Wang, Q. Wang, Haoxiang Xu, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 798
Closed Access
Huilan Wang, Q. Wang, Haoxiang Xu, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 798
Closed Access
In silico identification and in vitro evaluation of MRPS30‐DT lncRNA and MRPS30 gene expression in breast cancer
Nooshafarin Shirani, Roohallah Mahdi‐Esferizi, Reza Eshraghi Samani, et al.
Cancer Reports (2024) Vol. 7, Iss. 6
Open Access | Times Cited: 3
Nooshafarin Shirani, Roohallah Mahdi‐Esferizi, Reza Eshraghi Samani, et al.
Cancer Reports (2024) Vol. 7, Iss. 6
Open Access | Times Cited: 3
Folate-mediated targeted PLK1 inhibition therapy for ovarian cancer: A comparative study of molecular inhibitors and siRNA therapeutics
Zhe Wang, Songsong Zhao, Jun Shi, et al.
Acta Biomaterialia (2021) Vol. 138, pp. 443-452
Closed Access | Times Cited: 20
Zhe Wang, Songsong Zhao, Jun Shi, et al.
Acta Biomaterialia (2021) Vol. 138, pp. 443-452
Closed Access | Times Cited: 20
A polo-like kinase inhibitor identified by computational repositioning attenuates pulmonary fibrosis
Takeshi Imakura, Seidai Sato, Kazuya Koyama, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Takeshi Imakura, Seidai Sato, Kazuya Koyama, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Clinicopathological Significance of AKT1 and PLK1 Expression in Oral Squamous Cell Carcinoma
Ercan Sun, Shuangshuang Dong, Zhi-Jun Li, et al.
Disease Markers (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 7
Ercan Sun, Shuangshuang Dong, Zhi-Jun Li, et al.
Disease Markers (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 7
PLK3 is linked with higher tumor stage and unfavorable prognosis in patients with colorectal cancer
Hai Zeng, Qian Wang, Ying Xiang, et al.
Biomarkers in Medicine (2024) Vol. 18, Iss. 6, pp. 221-230
Closed Access | Times Cited: 1
Hai Zeng, Qian Wang, Ying Xiang, et al.
Biomarkers in Medicine (2024) Vol. 18, Iss. 6, pp. 221-230
Closed Access | Times Cited: 1
Inhibition of Polo-like Kinase 1 by HMN-214 Blocks Cell Cycle Progression and Inhibits Neuroblastoma Growth
Rameswari Chilamakuri, Danielle C. Rouse, Saurabh Agarwal
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 523-523
Open Access | Times Cited: 4
Rameswari Chilamakuri, Danielle C. Rouse, Saurabh Agarwal
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 523-523
Open Access | Times Cited: 4
Anlotinib Exerts Inhibitory Effects against Cisplatin-Resistant Ovarian Cancer In Vitro and In Vivo
Yurou Ji, Xinyu Li, Yue Qi, et al.
Molecules (2022) Vol. 27, Iss. 24, pp. 8873-8873
Open Access | Times Cited: 4
Yurou Ji, Xinyu Li, Yue Qi, et al.
Molecules (2022) Vol. 27, Iss. 24, pp. 8873-8873
Open Access | Times Cited: 4
Discovery of Polo-like Kinase 4 Inhibitors for the Treatment of Cancer: A Mini Patent Review
Zhouling Xie, Chenzhong Liao, Yang Shu, et al.
Mini-Reviews in Medicinal Chemistry (2022) Vol. 23, Iss. 1, pp. 67-79
Closed Access | Times Cited: 3
Zhouling Xie, Chenzhong Liao, Yang Shu, et al.
Mini-Reviews in Medicinal Chemistry (2022) Vol. 23, Iss. 1, pp. 67-79
Closed Access | Times Cited: 3
Regulation of intestinal stem cell activity by a mitotic cell cycle regulator Polo in Drosophila
Ying Zhang, Rongbing Chen, Liyuan Gong, et al.
G3 Genes Genomes Genetics (2023) Vol. 13, Iss. 6
Open Access | Times Cited: 1
Ying Zhang, Rongbing Chen, Liyuan Gong, et al.
G3 Genes Genomes Genetics (2023) Vol. 13, Iss. 6
Open Access | Times Cited: 1
MYC and HSF1 Cooperate to Drive PLK1 inhibitor Sensitivity in High Grade Serous Ovarian Cancer
Imade Williams, Haddie DeHart, Matthew W. O’Malley, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Imade Williams, Haddie DeHart, Matthew W. O’Malley, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Polo‐like kinase 1 inhibition modulates urinary tract smooth muscle contraction and bladder cell transcriptional programs
Xiaolong Wang, Linfa Guo, Zuhaer Yisha, et al.
Cytoskeleton (2024)
Closed Access
Xiaolong Wang, Linfa Guo, Zuhaer Yisha, et al.
Cytoskeleton (2024)
Closed Access
Genetic instability of lung induced by carbon black nanoparticles is related with Plk1 signals changes
Zijie Pei, Jie Ning, Ning Zhang, et al.
NanoImpact (2022) Vol. 26, pp. 100400-100400
Closed Access | Times Cited: 2
Zijie Pei, Jie Ning, Ning Zhang, et al.
NanoImpact (2022) Vol. 26, pp. 100400-100400
Closed Access | Times Cited: 2
Polo-Like Kinase 2 Plays an Essential Role in Cytoprotection against MG132-Induced Proteasome Inhibition via Phosphorylation of Serine 19 in HSPB5
Shuji Ueda, Moeka Nishihara, Yuuki Hioka, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11257-11257
Open Access | Times Cited: 2
Shuji Ueda, Moeka Nishihara, Yuuki Hioka, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11257-11257
Open Access | Times Cited: 2
A polo-like kinase inhibitor identified by computational repositioning attenuates pulmonary fibrosis
Takeshi Imakura, Seidai Sato, Kazuya Koyama, et al.
Research Square (Research Square) (2022)
Open Access
Takeshi Imakura, Seidai Sato, Kazuya Koyama, et al.
Research Square (Research Square) (2022)
Open Access
